Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trial.

Autor: Biran N; Myeloma Division John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey USA., Dhakal B; Division of Hematology and Oncology Department of Medicine Medical College of Wisconsin Milwaukee Wisconsin USA., Lentzsch S; Division of Hematology and Oncology Herbert Irving Comprehensive Cancer Center Columbia University New York New York USA., Siegel D; Myeloma Division John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey USA., Usmani SZ; Levine Cancer Institute Charlotte North Carolina USA., Rossi A; Department of Medical Oncology New York Presbyterian Hospital-Weill Cornell Medical Center Weill Cornell Medicine New York New York USA., Rosenbaum C; Department of Medical Oncology New York Presbyterian Hospital-Weill Cornell Medical Center Weill Cornell Medicine New York New York USA., Bhutani D; Division of Hematology and Oncology Herbert Irving Comprehensive Cancer Center Columbia University New York New York USA., Vesole DH; Myeloma Division John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey USA.; Multiple Myeloma Program Lombardi Comprehensive Cancer Center & Medstar Georgetown University Hospital Georgetown University Washington District of Columbia USA., Rodriguez C; Wake Forest Baptist Comprehensive Cancer Center Winston-Salem North Carolina USA., Nooka AK; Winship Cancer Institute Emory University Atlanta Georgia USA., van Rhee F; Myeloma Center University of Arkansas of Medical Sciences Little Rock Arkansas USA., Stork-Sloots L; Medex15 Amsterdam The Netherlands., de Snoo F; Medex15 Amsterdam The Netherlands., Bhattacharyya PK; Myeloma Division John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey USA., Dash DP; Versiti Blood Center of Wisconsin Milwaukee Wisconsin USA., Zümrütçü S; SkylineDx Rotterdam The Netherlands., van Vliet MH; SkylineDx Rotterdam The Netherlands., Hari P; Division of Hematology and Oncology Department of Medicine Medical College of Wisconsin Milwaukee Wisconsin USA., Niesvizky R; Department of Medical Oncology New York Presbyterian Hospital-Weill Cornell Medical Center Weill Cornell Medicine New York New York USA.

Publikováno v: EJHaem [EJHaem] 2021 May 11; Vol. 2 (3), pp. 375-384. Date of Electronic Publication: 2021 May 11 (Print Publication: 2021).